Calcipotriene Ointment
NDC Package 68462-310-65
Package Information
Calcipotriene ointment is a medication used to treat psoriasis. This formulation utilizes a ointment delivery system. Marketed by Glenmark Pharmaceuticals Inc., Usa, this product is identified by NDC 68462-310 and is authorized under FDA application ANDA090633.
Identification & Billing
- RxCUI: 198373 - calcipotriene 0.005 % Topical Ointment
- RxCUI: 198373 - calcipotriene 0.00005 MG/MG Topical Ointment
- RxCUI: 198373 - calcipotriene 50 MCG/GM Topical Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68462 - Glenmark Pharmaceuticals Inc., Usa
- 68462-310 - Calcipotriene
- 68462-310-65 - 60 g in 1 TUBE
- 68462-310 - Calcipotriene
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (68462-310). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68462-310-65 identifies a specific commercial package of 60 g in 1 tube of Calcipotriene, a human prescription drug labeled by Glenmark Pharmaceuticals Inc., Usa. This ointment is formulated for topical use and contains calcipotriene as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Glenmark Pharmaceuticals Inc., Usa on March 24, 2010. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat psoriasis. Calcipotriene is a form of vitamin D. It works by slowing down the growth of skin cells.
How is this Glenmark Pharmaceuticals Inc., Usa product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68462031065. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.